海正藥業(600267.SH)已提交了海正宣泰51%股權轉讓的掛牌申請
格隆匯10月31日丨海正藥業(600267.SH)公佈,2019年10月29日,公司第八屆董事會第五次會議審議通過了《關於轉讓控股孫公司浙江海正宣泰醫藥有限公司51%股權的議案》。基於公司“聚焦主業發展”經營發展戰略需要,同意公司全資子公司海正藥業(杭州)有限公司(“海正杭州公司”)將其持有的浙江海正宣泰醫藥有限公司(“海正宣泰”)51%股權通過產權交易所公開掛牌的方式進行對外轉讓。海正宣泰51%股權對應的評估價值為2339.51萬元,掛牌底價不低於評估價值。
公司已於2019年10月30日向台州市產權交易所有限公司(“台交所”)提交了海正宣泰51%股權轉讓的掛牌申請,相關股權將委託台交所通過公開掛牌方式轉讓。台交所定於2019年10月31日在其網站上發佈《(預披露項目)浙江海正宣泰醫藥有限公司51%股權轉讓項目》,並由台交所組織實施交易。
浙江海正宣泰醫藥有限公司51%股權轉讓項目預披露期限自2019年10月31日至2019年11月27日止,正式掛牌期自2019年11月28日至2019年12月25日下午4:00時止,同時《浙江海正宣泰醫藥有限公司51%股權轉讓文件》(台交所掛[2019]23號)將於2019年11月28日在台交所指定網站上發佈。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.